Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2025-12-25 @ 8:50 PM
NCT ID:
NCT05132569
Pre Assignment Details:
Randomization was stratified by Myasthenia Gravis Foundation of America (MGFA) class (II, IIIa/IVa, or IIIb/IVb) and region (United States \[US\], non-US). Due to early termination of the study by sponsor, several planned efficacy analysis were not performed for the study.
Recruitment Details:
Study was conducted at 22 sites in 9 countries from 03-Dec-2021 to 21-Feb-2023. A total of 6 participants were randomized in a 1:1 ratio to receive treatment with tolebrutinib or placebo.
Study:
NCT05132569
Study Brief:
Results Section:
NCT05132569